Kamala Harris supporters are protesting Elon Musk’s support for Donald Trump by leaving X for left-leaning social media alternatives, Bluesky and Threads.
Mark Zuckerberg launched Threads in 2023 to cater to users alienated by the lack of censorship on X. Threads is currently the top-rated “free” app in Apple Inc.’s App Store. According to Bloomberg, Threads has more than 275 million monthly users, up from 150 million in April.
Meanwhile, Bluesky has added more than 700,000 new users in the past week and now has 14.5 million total accounts, up from 10 million in September. The decentralized social network is best known for adding 1 million new sign-ups after Brazil shuttered X for allowing too much free speech.
Bluesky Chief Operating Officer Rose Wang touted the “diversity of communities coming to Bluesky” since the 2024 presidential election in an email to Bloomberg. However, the new users sound like just different communities within the demographic of depressed Kamala voters.
Specifically, Wang named the “Swifites” flocking to the service. […]
— Read More: www.outkick.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
